☆ 4.5 Article

The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients

BLOOD CANCER JOURNAL (2023)

Related references

Note: Only part of the references are listed.

Review Hematology

The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms

Jurgen Thiele et al.

Summary: A group of international experts met to update the World Health Organization classification system for hematopoietic tumors and introduced the new International Consensus Classification (ICC) for Myeloid Neoplasms and Acute Leukemias. The focus of this review is on the ICC-2022 category of JAK2 mutation-prevalent myeloproliferative neoplasms (MPNs) and the importance of bone marrow morphology and genetic markers in disease classification and diagnostics.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Add to Collection

Article Hematology

Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management

Ayalew Tefferi et al.

Summary: Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by clonal erythrocytosis caused by JAK2 mutation. It presents with leukocytosis, thrombocytosis, splenomegaly, pruritus, constitutional symptoms, microcirculatory disturbances, and increased risk of thrombosis and progression into myelofibrosis or acute myeloid leukemia.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Add to Collection

Article Oncology

Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms

Andrew Schafer

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Review Hematology

The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms

Hans Carl Hasselbalch et al.

Summary: Thrombotic, vascular, and bleeding complications are common causes of morbidity and mortality in Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs). Abnormalities in circulating cells in MPNs create a prothrombotic environment, leading to venous, arterial, and microvascular thrombosis. The inflammatory state of MPN stem cells amplifies the clinical thrombotic tendency and promotes further MPN stem cell clonal expansion.

BLOOD (2021)

Add to Collection

Article Multidisciplinary Sciences

Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis

S. Avagyan et al.

Summary: Research has found that mutations in clonal hematopoiesis enhance the fitness of hematopoietic stem cells, and mutations in specific genes can promote clonal dominance. Single-cell transcriptional analysis showed that these mutations stimulate the expression of inflammatory genes in mature myeloid cells and anti-inflammatory genes in progenitor cells of the mutant clone.

SCIENCE (2021)

Add to Collection

Editorial Material Hematology

An agenda for future research projects in polycythemia vera and essential thrombocythemia

Tiziano Barbui et al.

HAEMATOLOGICA (2020)

Add to Collection

Article Medicine, General & Internal

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Natasha Szuber et al.

MAYO CLINIC PROCEEDINGS (2019)

Add to Collection

Article Mathematical & Computational Biology

Parametric multistate survival models: Flexible modelling allowing transition-specific distributions with application to estimating clinically useful measures of effect differences

Michael J. Crowther et al.

STATISTICS IN MEDICINE (2017)

Add to Collection

Article Hematology

Inflammation: a key regulator of hematopoietic stem cell fate in health and disease

Eric M. Pietras

BLOOD (2017)

Add to Collection

Review Hematology

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A. Arber et al.

BLOOD (2016)

Add to Collection

Review Oncology

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

S. Cerquozzi et al.

BLOOD CANCER JOURNAL (2015)

Add to Collection

Letter Hematology

In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology

Tiziano Barbui et al.

BLOOD (2014)

Add to Collection

Article Oncology

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

A. Tefferi et al.

LEUKEMIA (2013)

Add to Collection

Article Hematology

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

James W. Vardiman et al.

BLOOD (2009)

Add to Collection

Letter Oncology

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment

G. Barosi et al.

LEUKEMIA (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.